Author: Sundquist J1, Palmér K1, Memon AA1, Wang X1, Johansson LM1, Sundquist K1
Affiliation: <sup>1</sup>Center for Primary Health Care Research, Lund University, Clinical Research Centre (CRC), Malmö, Sweden.
Conference/Journal: Early Interv Psychiatry.
Date published: 2018 Jul 3
Other:
Special Notes: doi: 10.1111/eip.12715. [Epub ahead of print] , Word Count: 244
BACKGROUND: Although mindfulness-based group therapies (MGTs) for depressive, anxiety or stress and adjustment disorders are promising, there is a substantial lack of knowledge regarding the long-term improvements after such therapies in these common psychiatric disorders.
METHODS: Two hundred and fifteen patients were randomized in a randomized clinical trial (RCT) (ClinicalTrials.gov ID: NCT01476371) conducted in 2012 at 16 primary healthcare centres in southern Sweden. The patients were randomized to MGT or treatment as usual (TAU) and completed four psychometric self-rated scales after 8 weeks of treatment. Approximately 12 months after the completion of the 8-week treatment, the same scales were repeated. Ordinal and generalized linear-mixed models, adjusted for cluster effects, were used for the analysis.
RESULTS: For all four psychometric scales (MADRS-S [Montgomery-Åsberg Depression Rating Scale-S], HADS-D, HADS-A [Hospital Anxiety and Depression Scale A and D] and PHQ-9 [Patient Health Questionnaire-9]) the scores at the 1-year follow-up were significantly improved (all P values <0.001) in both groups. Furthermore, there were no significant differences between the MGT and TAU in the psychometric scores at the 1-year follow-up.
CONCLUSIONS: To the best of our knowledge, this is the first RCT comparing the long-term improvements after MGT with TAU. Although it cannot be excluded that our findings are a result of the natural course of common psychiatric disorders or other factors, they suggest a long-term positive improvement after both MGT and TAU.
© 2018 John Wiley & Sons Australia, Ltd.
KEYWORDS: anxiety; depression; mindfulness; primary healthcare; randomized controlled trial
PMID: 29968371 DOI: 10.1111/eip.12715